Company Filing History:
Years Active: 2011
Title: Innovations of Yingchun Lu in Immunosuppression
Introduction
Yingchun Lu is a notable inventor based in Kendall Park, NJ (US). He has made significant contributions to the field of immunosuppression through his innovative research and development of novel compounds. With a total of 2 patents, his work focuses on addressing autoimmune diseases and transplant rejection.
Latest Patents
Yingchun Lu's latest patents include "8-substituted 2-(benzimidazolyl)purine derivatives for immunosuppression." This invention provides novel purines that are useful for the prevention and treatment of autoimmune diseases, inflammatory diseases, mast cell-mediated diseases, and transplant rejection. The compounds are characterized by a general formula where Q is selected from the group consisting of CX and nitrogen, and A is chosen from various groups including alkyl, heterocyclyl, aryl, substituted alkyl, substituted heterocyclyl, substituted aryl, and halogen. Another significant patent is "Purine and imidazopyridine derivatives for immunosuppression," which also aims to provide novel derivatives for similar medical applications.
Career Highlights
Yingchun Lu has been associated with Wyeth, a prominent company in the pharmaceutical industry. His work at Wyeth has allowed him to focus on developing innovative solutions for critical health issues.
Collaborations
Yingchun Lu has collaborated with notable colleagues such as Adolph C Bohnstedt and Celia Kingsbury. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Yingchun Lu's contributions to immunosuppression through his innovative patents highlight his role as a significant inventor in the pharmaceutical field. His work continues to impact the treatment of autoimmune diseases and transplant rejection.